NYSE ARCA | ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index.
It will normally invest at least 80% of its net assets in securities that comprise the underlying index.
The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of theU. S.
Food and Drug Administration clinical trials.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 5.51% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.36% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.38% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 3.93% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 3.84% |
| VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.74% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.53% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 3.38% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.19% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.08% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 2.97% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.73% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.54% |
| IMVT | Immunovant Inc | Healthcare | Biotechnology | 2.53% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 2.29% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.24% |
| VRNA | Verona Pharma PLC ADR | Healthcare | Biotechnology | 2.12% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 2.08% |
| MRUS | Merus BV | Healthcare | Biotechnology | 2.06% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 2.03% |